• Health & Medicine

Chemotherapy free treatment for leukaemia given the green light for NHS in England

A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England. A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.

13 November 2020

• Health & Medicine

Four new cancer drugs approved on NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

13 November 2020

• Health & Medicine
• Policy & Insight

Learning the lessons of COVID-19: Protecting cancer services and research through the pandemic

We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve. We're calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.

9 November 2020

• Health & Medicine

Scientists develop next-generation immunotherapy now entering early phase clinical trials

Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system. Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.

9 November 2020

• Health & Medicine

Immunotherapy drug approved for head and neck cancer

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

26 October 2020

• Policy & Insight

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research. This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here's why it's time to invest in cancer services and research.

20 October 2020

• Policy & Insight

NHS staff shortages: What’s needed to build a sustainable cancer workforce?

We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%. We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.

12 October 2020

• Health & Medicine

New drug targeting high-risk children’s cancer is ready for trials

A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma. A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.

5 October 2020

• Health & Medicine

What’s happened to cancer services during the COVID-19 pandemic?

Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering. Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering.

11 September 2020

• Health & Medicine

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant. Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

10 September 2020

• Health & Medicine

Rare bowel cancer treatment combo gets initial no for NHS use in England  

A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence. A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.

4 September 2020

• Health & Medicine

The changing landscape of children's cancer treatment

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored. We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored.

2 September 2020